Browse by author
Lookup NU author(s): Dr Ahmad Khundakar,
Professor Alan Thomas
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Depression is among the most common behavioral and psychological symptoms of dementia, and leads to more rapid decline and higher mortality. Treatment for depression in dementia has centered on conventional antidepressant drug treatment based around the monoamine hypothesis of depression. However, recent major studies have suggested that conventional antidepressant treatments that aim to correct underlying deficits in monoamine neurotransmitters are not effective for depression in dementia. Postmortem studies have also suggested that depression in dementia does not arise from serotonergic or noradrenergic abnormalities, or indeed from the degenerative pathology associated with Alzheimer's disease. In contrast, considerable recent evidence has suggested that alterations in glutamatergic transmission may contribute to the pathophysiology of depression. This supports the view that treatment-resistant depressed patients, such as many dementia patients, may benefit from agents affecting glutamate transmission. This review will thus draw together the wealth of pathological data examining the basis of depression in Alzheimer's disease and relate this to current thinking on treatment, with the aim of generating discussion on potential novel therapeutic strategies.
Author(s): Khundakar AA, Thomas AJ
Publication type: Book Chapter
Publication status: Published
Book Title: Handbook of Depression in Alzheimer’s Disease
Print publication date: 01/07/2015
Acceptance date: 01/04/2015
Series Title: Advances in Alzheimer's Disease
Number of Volumes: 4
Publisher: IOS Press
Place Published: Amsterdam
Library holdings: Search Newcastle University Library for this item